NL125068C - - Google Patents

Info

Publication number
NL125068C
NL125068C NL125068DA NL125068C NL 125068 C NL125068 C NL 125068C NL 125068D A NL125068D A NL 125068DA NL 125068 C NL125068 C NL 125068C
Authority
NL
Netherlands
Application number
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication of NL125068C publication Critical patent/NL125068C/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J1/00Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J41/00Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J75/00Processes for the preparation of steroids in general

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL125068D 1964-06-01 NL125068C (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX7727364 1964-06-01

Publications (1)

Publication Number Publication Date
NL125068C true NL125068C (en:Method)

Family

ID=19743026

Family Applications (2)

Application Number Title Priority Date Filing Date
NL125068D NL125068C (en:Method) 1964-06-01
NL6506952A NL6506952A (en:Method) 1964-06-01 1965-06-01

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6506952A NL6506952A (en:Method) 1964-06-01 1965-06-01

Country Status (6)

Country Link
US (1) US3277122A (en:Method)
CH (1) CH468985A (en:Method)
DE (1) DE1493054C3 (en:Method)
FR (1) FR1435502A (en:Method)
GB (1) GB1090242A (en:Method)
NL (2) NL6506952A (en:Method)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3370071A (en) * 1965-06-01 1968-02-20 Merck & Co Inc 3-keto-13beta-alkyl-17beta-acetyl-gona-4, 9-dienes and process
CH488682A (de) * 1965-07-30 1970-04-15 Ciba Geigy Verfahren zur Herstellung von 4,9,11-Trienen der 19-Nor-androstanreihe
FR2077877B1 (en:Method) * 1970-02-20 1974-02-01 Roussel Uclaf
US3761591A (en) * 1970-02-20 1973-09-25 Roussel Uclaf Novel pregnadiene
US3919267A (en) * 1970-03-03 1975-11-11 Roussel Uclaf 13{62 -ethyl-17{60 -methyl-18,19-dinor-{66 {hu 4,9{b -pregnadiene-3,20-dione
NL7710462A (nl) * 1977-09-26 1979-03-28 Akzo Nv Werkwijze voor het bereiden van nieuwe steroiden van de pregnaanreeks.

Also Published As

Publication number Publication date
DE1493054A1 (de) 1969-06-12
GB1090242A (en) 1967-11-08
CH468985A (de) 1969-02-28
DE1493054C3 (de) 1973-01-04
FR1435502A (fr) 1966-04-15
US3277122A (en) 1966-10-04
NL6506952A (en:Method) 1965-12-02

Similar Documents

Publication Publication Date Title
AU4679664A (en:Method)
BE642367A (en:Method)
BE642316A (en:Method)
BE660517A (en:Method)
BE659881A (en:Method)
BE659839A (en:Method)
NL125068C (en:Method)
BE659489A (en:Method)
BE659046A (en:Method)
BE658899A (en:Method)
BE658070A (en:Method)
BE657816A (en:Method)
BE657231A (en:Method)
BE657172A (en:Method)
BE656829A (en:Method)
BE647877A (en:Method)
BE642974A (en:Method)
BE642797A (en:Method)
BE642770A (en:Method)
BE642741A (en:Method)
BE642735A (en:Method)
BE642654A (en:Method)
BE642652A (en:Method)
BE642589A (en:Method)
BE642588A (en:Method)